- Jean Martin | January 29, 2008 1:38 PM |
Category:
Defective & Dangerous ProductsA lawsuit filed in New Jersey state court claims that Fosamax caused multiple stress fractures and suppressed bone regeneration in the legs of a woman who took Fosamax for 10 years. More than 400 people already have sued manufacturer Merck alleging that Fosamax causes a bone-decaying condition known as osteonecrosis of the jaw. Osteonecrosis of the jaw is a serious condition in which bone...
- Jean Martin | January 29, 2008 9:52 AM |
Category:
Defective & Dangerous ProductsBaxter Healthcare Corporation has announced the voluntary recall of multiple lots of its blood thinner Heparin. Heparin is used to prevent blood clots in people who have certain medical conditions or who are undergoing certain medical procedures that increase the chance that clots will form. The doses subject to the recall are primarily used for hemodialysis and cardiac invasive procedures....
- Jean Martin | January 25, 2008 5:05 PM |
Category:
Defective & Dangerous ProductsThe judge hearing the cases in the Kugel Mesh Patch Litigation MDL has recently expanded the scope of the MDL to include more hernia mesh patches than what had been recalled. The judge opened up the MDL to include additional Davol and Bard mesh patches, including some that did not contain an internal ring, but were made of a special bi-layered material similar to the Kugel Mesh patches.What...
- Jean Martin | January 25, 2008 4:02 PM |
Category:
Defective & Dangerous ProductsMany patients who had experienced abdominal pain, constipation, bowel obstructions and bowel adhesions after hernia repair surgery contacted a lawyer to determine their legal rights only to be told that they did not have a case because the specific mesh patch used in their surgery was not subject to a recall. We at Shipman & Wright, LLP knew that the defect in the patches had to go beyond any...
- Jean Martin | January 24, 2008 1:40 PM |
Category:
Defective & Dangerous ProductsYesterday the FDA approved changes to the Ortho Evra label that includes the results of a new epidemiology study that found that users of the Ortho Evra birth control patch were at higher risk of developing serious blood clots as compared to women who take birth control pills. This latest study, conducted on behalf of Ortho Evra manufacturer Johnson & Johnson, reiterates findings of two studies...
- Jean Martin | January 23, 2008 6:31 PM |
Category:
Defective & Dangerous ProductsA study conducted on behalf of manufacturer Johnson & Johnnson revealed that women using the Ortho Evra Contraceptive Patch are at a higher risk of developing serious blood clots than those who use birth control pills. These recent findings reiterate those from an earlier study finding that women, ages 15 - 44, who use the Ortho Evra skin patch have a greater risk for developing a condition...
- Jean Martin | January 23, 2008 6:05 PM |
Category:
Defective & Dangerous ProductsThe makers of Vytorin and Zetia have announced that they are pulling TV ads for the drugs. The companies waited a whole week to take this action after it was reported that a study found that Zetia was not effective at reducing cholesterol and that Vytorin was no more effective than the much cheaper Zocor (Vytorin is a combination of Zetia and Zocor), and might actually be worse. The study...
- Jean Martin | January 21, 2008 12:16 PM |
Category:
Workplace InjuriesThe time is always right to do what is right. - Martin Luther King, Jr.As we reflect on all that Martin Luther King, Jr. was able to accomplish in his life cut too short, one can only wonder what he could have achieved for workers' rights and what he could have done to end the on-going discrimination in the workplace. Everyone is quite familiar with his accomplishments in stomping out racial...
- Jean Martin | January 15, 2008 10:26 AM |
Category:
Defective & Dangerous ProductsZetia and Vytorin are not effective, and worse, may actually do more harm than good. Study results that were delayed in being publicized the reports show that while Zetia and Vytorin may slightly reduce cholesterol, they do not reduce plaque build-up in the arteries, and in some cases actually increase the production of plaque. This is not good news for the millions of people who are paying as...
- Jean Martin | January 15, 2008 9:38 AM |
Category:
Defective & Dangerous ProductsYesterday it was announced that, once again, new highly-touted medications are not effective, and worse, may actually do more harm than good. Results from a study regarding Zetia and Vytorin were finally released after much delay and speculation. Much to the public's chagrin, the reports are that Zetia and Vytorin may slightly reduce cholesterol, but they do not reduce plaque build-up in the...
- Jean Martin | January 14, 2008 1:25 PM |
Category:
Defective & Dangerous ProductsImplantable defibrillators that are intended to save lives may malfunction and cause injury to the very people intended to be helped. There are increasing reports that leads used in Medtronic and St. Jude implantable defibrillators --specifically in the Medtronic Sprint Fidelis leads and St. Jude Riata lead wires-- have fractured or separated, perforating the heart walls, causing the device to...
- Matt Buckmiller | January 10, 2008 6:14 PM |
Category:
Defective & Dangerous ProductsModular homes are homes built in modules at a factory. A modular home is required to conform to all state, local, and regional codes where the home is to be placed. While most homeowners share the sentiment that there are less likely to be problems with modular homes then on-site constructed homes, nothing could be further then the truth. While in most cases, the modular home is free from...
- Gary Shipman | January 09, 2008 12:30 PM |
Category:
Defective & Dangerous ProductsOn January 8, 2008, a Federal Court judge in Rhode Island expanded the scope of the consolidated proceedings involving hernia patches manufactured by Davol/Bard to cover all Davol Marlex/Teflon products, with or without "memory recoil rings." On August 25, 2000, Davol/Bard submitted an application to the Federal Drug Administration to notify of its intent to market the Composix® E/X Mesh Patch...
- Gary Shipman | January 08, 2008 9:00 AM |
Category:
Defective & Dangerous ProductsOn Monday, the FDA issued a warning to doctors and patients about the possibility of debilitating bone, joint or muscle pain associated with the use of various drugs, including Fosamax, Boniva, Zometa, Reclast and Actional.The drugs that are the subject matter of the warning are known as biophosphonates, and are used to treat osteoporosis and other bone-thinning diseases. According to the FDA,...